Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Bernstein

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
PPAR Research|June 6, 2008
Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesTatiana M Garcia-Bates, Geniece M Lehmann, Patricia J Simpson-Haidaris, et al.
Clinical Immunology (Orlando, Fla.)|September 28, 2005
B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cellsQiang Lou, Thomas F Conway, Nejat K Egilmez, et al.
Immunological Investigations|August 19, 2006
More than structural cells, fibroblasts create and orchestrate the tumor microenvironmentCarolyn J Baglole, Denise M Ray, Steven H Bernstein, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2018
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapiesKaty L Simonsen, Paula M Fracasso, Steven H Bernstein, et al.
Leukemia & Lymphoma|February 7, 2013
Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trialsMelhem Solh, Richard I Fisher, André Goy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody productionElizabeth P Ryan, Stephen J Pollock, Stephen J Pollack, et al.
Leukemia & Lymphoma|October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab eraMakiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
European Journal of Immunology|April 24, 2016
Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodesIgor I Kuzin, Stephen L Kates, Yawen Ju, et al.
The Oncologist|August 4, 2007
Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancerAntoni Ribas, Douglas C Hanson, Dennis A Noe, et al.
Experimental Hematology|August 31, 2006
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathwayDenise M Ray, Kimberly M Morse, Shannon P Hilchey, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
PPAR Research|June 6, 2008
Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesTatiana M Garcia-Bates, Geniece M Lehmann, Patricia J Simpson-Haidaris, et al.
Clinical Immunology (Orlando, Fla.)|September 28, 2005
B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cellsQiang Lou, Thomas F Conway, Nejat K Egilmez, et al.
Immunological Investigations|August 19, 2006
More than structural cells, fibroblasts create and orchestrate the tumor microenvironmentCarolyn J Baglole, Denise M Ray, Steven H Bernstein, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2018
The Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapiesKaty L Simonsen, Paula M Fracasso, Steven H Bernstein, et al.
Leukemia & Lymphoma|February 7, 2013
Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trialsMelhem Solh, Richard I Fisher, André Goy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody productionElizabeth P Ryan, Stephen J Pollock, Stephen J Pollack, et al.
Leukemia & Lymphoma|October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab eraMakiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
European Journal of Immunology|April 24, 2016
Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodesIgor I Kuzin, Stephen L Kates, Yawen Ju, et al.
The Oncologist|August 4, 2007
Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancerAntoni Ribas, Douglas C Hanson, Dennis A Noe, et al.
Experimental Hematology|August 31, 2006
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathwayDenise M Ray, Kimberly M Morse, Shannon P Hilchey, et al.
Pageof 6